Phoenix, AZ

Pediatric Neurologist, Phoenix Children’s Hospital

Represented: Researchers

Michael Kruer, MD, attended Arizona State University (undergraduate), the University of Arizona (medical school), and performed postdoctoral work at the Translational Genomics Research Institute in Phoenix. Kruer then trained in pediatrics at Phoenix Children’s Hospital and in pediatric neurology and developmental medicine and molecular neurogenetics at Oregon Health & Science University. He currently works as a physician scientist at Phoenix Children’s Hospital. Kruer became passionate about movement disorders and rare disease while trying to help families find answers and hope. Those experiences led Kruer to combine his clinical interests with a translational laboratory research program. He is currently the director of the Pediatric Movement Disorders Center and the Program in Neurogenetics & Undiagnosed Neurological Diseases at Phoenix Children’s Hospital. He is also the principal investigator for the Cerebral Palsy Genetic Research Network (CPGRN), a nonprofit worldwide collaborative seeking to understand the genetic basis of CP in order to help develop better diagnostics and treatments. Kruer’s research has been supported by the Dystonia Medical Research Foundation, the US National Institutes of Health, and the American Academy of Cerebral Palsy and Developmental Medicine, among others. His awards include selection as an American Academy of Neurology Clinical Research Fellow, a Clinical Scientist Development Award from the Doris Duke Charitable Foundation, and the Shields Award from the Child Neurology Society.

Kruer served as a member of the Advisory Panel on Rare Disease from Spring 2016 - August 2017.

Conflicts of Interest

As of August 8, 2016

  • Speakers’ Bureau, Tourette Association of America (2016-present)
  • Consultant, HRSA National Vaccine Injury & Compensation Program (2015-present)
  • Grant support, Retrophin (2014-present)
  • Speakers’ Bureau, Huntington Disease Society of America (2015-present)
  • Advisory committee, Lundbeck (2015)
  • Grant review, Department of Defense (2013, 2014, 2016)
  • Consultant, eMedicine, Lysosomal Storage Disease, Myoclonic epilepsy (2011-present)


Person Type